Risk of atypical femoral fracture during and after bisphosphonate use

Risk of Atypical Femoral Fracture during and after Bisphosphonate Use

(2014) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology, radiology and histology of atypical femoral fractures

(2013) Jörg Schilcher   Acta Orthopaedica

Proposed pathogenesis for atypical femoral fractures: Lessons from materials research

(2013) B. Ettinger et al.   BONE

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis

(2013) Lydia Gedmintas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

(2013) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence

(2013) Ie-Wen Sim et al.   Therapeutic Advances in Musculoskeletal Disease

Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use

(2012) Raphael P. H. Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls

(2012) Jörg Schilcher et al.   BONE

Incidence and demography of femur fractures with and without atypical features

(2012) Adrianne C Feldstein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Incidence of atypical nontraumatic diaphyseal fractures of the femur

(2012) Richard M Dell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonates for Osteoporosis — Where Do We Go from Here?

(2012) Marcea Whitaker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?

(2012) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonates for postmenopausal osteoporosis

(2011) Richard Eastell et al.   BONE

The relationship between the chemistry and biological activity of the bisphosphonates

(2011) Frank H. Ebetino et al.   BONE

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical fractures of the femur and bisphosphonate therapy

(2010) Andrea Giusti et al.   BONE

Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry

(2010) M. F. Bergstrom et al.   INJURY PREVENTION

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical Femoral Fractures and Bisphosphonate Use

(2010) Christian M. Girgis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral bisphosphonate compliance and persistence: a matter of choice?

(2010) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

(2009) Jörg Schilcher et al.   Acta Orthopaedica

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates

(2009) Kuntheavy Ing-Lorenzini et al.   DRUG SAFETY

Effectiveness of bisphosphonate therapy in a community setting

(2008) Adrianne C. Feldstein et al.   BONE

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence

(2008) Charles A. Inderjeeth et al.   BONE

Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users

(2008) Jeffrey R Curtis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone quality: the material and structural basis of bone strength

(2007) Ego Seeman   JOURNAL OF BONE AND MINERAL METABOLISM